Role of Sentinel Lymph Node Dissection in Vulvar Carcinoma
Article Sidebar
Published:
Mar 1, 2017
Keywords:
vulvar carcinoma sentinel lymph node
Main Article Content
Abstract
Vulvar carcinoma is an uncommon cancer. The incidence is 4% of all gynecologic cancer.The main treatment of vulvar carcinoma is surgery that consists of primary tumor resection and groin node dissection. Many complications can be occurred following the groin node dissection such as lymphocyst, lymphedema, and cellulitis. This aim of this literature review is to find the efficacy of sentinel lymph node (SLN; the first group of lymph node that the tumor passes through) dissection which evaluated with frozen section. The metastatic SLN group then underwent groin node dissection while the negative SLN group omitted such procedure. The results showed that SLN dissection can replace the unnecessary groin node dissection and reduce the complications from this procedure without deteriorating the patient outcome.
Article Details
How to Cite
Srijaipracharoen, S., & Chandeying, N. (2017). Role of Sentinel Lymph Node Dissection in Vulvar Carcinoma. Vajira Medical Journal : Journal of Urban Medicine, 61(1), 67–74. Retrieved from https://he02.tci-thaijo.org/index.php/VMED/article/view/195206
Section
Review Articles
References
1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013.
2. Berman ML, Soper JT, Creasman WT, Olt GT, DiSaia PJ. Conservative surgical management of superficially invasive stage I vulvar carcinoma.Gynecol Oncol. 1989 ;35: 352-7.
3. Hawnaur JM, Reynolds K, Wilson G, Hillier V, Kitchener HC. Identification of inguinal lymph node metastases from vulval carcinoma by magnetic resonance imaging: an initial report. Clin Radiol. 2002; 57: 995-1000.
4. Sohaib SA, Richards PS, Ind T, Jeyarajah AR, Shepherd JH, Jacobs IJ, et al. MR imaging of carcinoma of the vulva. AJR Am J Roentgenol. 2002 ; 178: 373-7.
5. R.M. Cabanas. An approach for the treatment of penile carcinoma. Cancer. 1977; 39: 456-66.
6. Levenback CF, Burke TW, Gershenson DM, Morris M, Malpica A, Ross M. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994; 84: 163-7.
7. Levenback CF, Burke TW, Morris M, Malpica A, Lucas K, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995; 59: 216-20.
8. Moore RG, Granai CO, Gajewski W, Gordinier M, Steinhoff MM. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol. 2003; 91: 378-82.
9. Ansink A, Sie-Go DM, van der Velden J, Sijmons EA, Lopes A, Monaghan JM, et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection. Cancer. 1999; 86: 652-6.
10. Levenback C, Coleman RL, Burke TW, Bodurka - Bevers D, Wolf JK, Gerdhenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001; 82: 276-81.
11. De Cicco C, Sideri M, Bartolomei M, Grana C, Cermonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Obstet Gynaecol. 2000; 82: 295-9.
12. de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, et al. Sentinel lymph node procedure is highly accurate in squmaous cell carcinoma of the vulva. J Clin Oncol. 2000; 18: 2811-6.
13. Sideri M, De Cicco C, Maggioni A, Colombo N, Bocciolone L, Trifiro G, et al. Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori. 2000; 86: 359-63.
14. Puig-Tintore LM, Ordi J, Vidal-Sicart S, Lejarcegui JA, Torne A, Pahisa J, et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol. 2003; 88: 29-34.
15. de Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, et al. Sentiel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med. 1998; 39: 1381-5.
16. Sliutz G, Reinthaller A, Lantzsch T, Mende T, Sinzinger H, Kainz C, et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol. 2002; 84: 449-52.
17. Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph node in vulvar cancer. Cancer. 2007; 110: 1015-23.
18. Meads C, Sutton AJ, Rosenthal AN, Malysiak S, Kowalska M, Zapalska A, et al. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer. 2014; 110: 2837-46.
19. Lawrie TA, Patel A, Martin-Hirsch PPL, Bryant A, Ratnavelu NDG, Naik R, et al. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. Cochrane Database Syst Rev. 2014; 6: CD010409.
20. Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008; 26: 884-9.
21. Coleman RL, Ali S, Levenback CF, Gold MA,Fowler JM, Judson PL. Is Bilateral Lymphadenectomy for Midline Squamous Carcinoma Of The Vulva Always Necessary? An Analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013; 128: 155-9.
22. Te Grootenhuis NC, Van der Zee AG, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V. Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen international Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2015; 140: 8-14.
23. Schutter EM, van de Sijde R. Evaluation of groin recurrence after sentinel node procedure in vulvar cancer is mandatory. Int J Gynecol Cancer. 2014; 24: 1138.
2. Berman ML, Soper JT, Creasman WT, Olt GT, DiSaia PJ. Conservative surgical management of superficially invasive stage I vulvar carcinoma.Gynecol Oncol. 1989 ;35: 352-7.
3. Hawnaur JM, Reynolds K, Wilson G, Hillier V, Kitchener HC. Identification of inguinal lymph node metastases from vulval carcinoma by magnetic resonance imaging: an initial report. Clin Radiol. 2002; 57: 995-1000.
4. Sohaib SA, Richards PS, Ind T, Jeyarajah AR, Shepherd JH, Jacobs IJ, et al. MR imaging of carcinoma of the vulva. AJR Am J Roentgenol. 2002 ; 178: 373-7.
5. R.M. Cabanas. An approach for the treatment of penile carcinoma. Cancer. 1977; 39: 456-66.
6. Levenback CF, Burke TW, Gershenson DM, Morris M, Malpica A, Ross M. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994; 84: 163-7.
7. Levenback CF, Burke TW, Morris M, Malpica A, Lucas K, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995; 59: 216-20.
8. Moore RG, Granai CO, Gajewski W, Gordinier M, Steinhoff MM. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol. 2003; 91: 378-82.
9. Ansink A, Sie-Go DM, van der Velden J, Sijmons EA, Lopes A, Monaghan JM, et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection. Cancer. 1999; 86: 652-6.
10. Levenback C, Coleman RL, Burke TW, Bodurka - Bevers D, Wolf JK, Gerdhenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001; 82: 276-81.
11. De Cicco C, Sideri M, Bartolomei M, Grana C, Cermonesi M, Fiorenza M, et al. Sentinel node biopsy in early vulvar cancer. Br J Obstet Gynaecol. 2000; 82: 295-9.
12. de Hullu JA, Hollema H, Piers DA, Verheijen RH, van Diest PJ, Mourits MJ, et al. Sentinel lymph node procedure is highly accurate in squmaous cell carcinoma of the vulva. J Clin Oncol. 2000; 18: 2811-6.
13. Sideri M, De Cicco C, Maggioni A, Colombo N, Bocciolone L, Trifiro G, et al. Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori. 2000; 86: 359-63.
14. Puig-Tintore LM, Ordi J, Vidal-Sicart S, Lejarcegui JA, Torne A, Pahisa J, et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol. 2003; 88: 29-34.
15. de Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, et al. Sentiel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med. 1998; 39: 1381-5.
16. Sliutz G, Reinthaller A, Lantzsch T, Mende T, Sinzinger H, Kainz C, et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol. 2002; 84: 449-52.
17. Hauspy J, Beiner M, Harley I, Ehrlich L, Rasty G, Covens A. Sentinel lymph node in vulvar cancer. Cancer. 2007; 110: 1015-23.
18. Meads C, Sutton AJ, Rosenthal AN, Malysiak S, Kowalska M, Zapalska A, et al. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer. 2014; 110: 2837-46.
19. Lawrie TA, Patel A, Martin-Hirsch PPL, Bryant A, Ratnavelu NDG, Naik R, et al. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. Cochrane Database Syst Rev. 2014; 6: CD010409.
20. Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008; 26: 884-9.
21. Coleman RL, Ali S, Levenback CF, Gold MA,Fowler JM, Judson PL. Is Bilateral Lymphadenectomy for Midline Squamous Carcinoma Of The Vulva Always Necessary? An Analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013; 128: 155-9.
22. Te Grootenhuis NC, Van der Zee AG, van Doorn HC, van der Velden J, Vergote I, Zanagnolo V. Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen international Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol. 2015; 140: 8-14.
23. Schutter EM, van de Sijde R. Evaluation of groin recurrence after sentinel node procedure in vulvar cancer is mandatory. Int J Gynecol Cancer. 2014; 24: 1138.